Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma
出版年份 2018 全文链接
标题
Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma
作者
关键词
-
出版物
OncoImmunology
Volume 7, Issue 7, Pages e1440930
出版商
Informa UK Limited
发表日期
2018-02-21
DOI
10.1080/2162402x.2018.1440930
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combined Anti-VEGF and Anti–CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes
- (2017) Xinqi Wu et al. Cancer Immunology Research
- Galectin 3 as a guardian of the tumor microenvironment
- (2016) Peter P. Ruvolo BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- T follicular regulatory cells
- (2016) Peter T. Sage et al. IMMUNOLOGICAL REVIEWS
- Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation
- (2016) Guoqing Cai et al. TUMOR BIOLOGY
- A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion
- (2016) Anne-Elisabeth Petit et al. Nature Communications
- VEGF Neutralization Plus CTLA-4 Blockade Alters Soluble and Cellular Factors Associated with Enhancing Lymphocyte Infiltration and Humoral Recognition in Melanoma
- (2016) X. Wu et al. Cancer Immunology Research
- Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy
- (2016) Xinqi Wu et al. Cancer Immunology Research
- Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments
- (2016) Ana Carolina Ferreira Cardoso et al. Frontiers in Oncology
- VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation
- (2015) Hua Huang et al. FASEB JOURNAL
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T follicular regulatory cells in the regulation of B cell responses
- (2015) Peter T. Sage et al. TRENDS IN IMMUNOLOGY
- Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
- (2015) T. Kouo et al. Cancer Immunology Research
- The Coinhibitory Receptor CTLA-4 Controls B Cell Responses by Modulating T Follicular Helper, T Follicular Regulatory, and T Regulatory Cells
- (2014) Peter T. Sage et al. IMMUNITY
- Tumor-released Galectin-3, a Soluble Inhibitory Ligand of Human NKp30, Plays an Important Role in Tumor Escape from NK Cell Attack
- (2014) Wei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pretreatment Serum VEGF Is Associated with Clinical Response and Overall Survival in Advanced Melanoma Patients Treated with Ipilimumab
- (2014) J. Yuan et al. Cancer Immunology Research
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma
- (2014) F. S. Hodi et al. Cancer Immunology Research
- Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages
- (2014) Camila Maria Longo Machado et al. Cancer Medicine
- Extracellular Galectin-3 in Tumor Progression and Metastasis
- (2014) Anneliese Fortuna-Costa et al. Frontiers in Oncology
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Regulation of galectin-3-induced apoptosis of Jurkat cells by bothO-glycans andN-glycans on CD45
- (2013) Jing Xue et al. FEBS LETTERS
- Galectin-3 Negatively Regulates Dendritic Cell Production of IL-23/IL-17-Axis Cytokines in Infection by Histoplasma capsulatum
- (2013) S.-Y. Wu et al. JOURNAL OF IMMUNOLOGY
- The roles of Galectin-3 in autoimmunity and tumor progression
- (2012) Gordana Radosavljevic et al. IMMUNOLOGIC RESEARCH
- The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood
- (2012) Peter T Sage et al. NATURE IMMUNOLOGY
- A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans
- (2011) Shigeru Tsuboi et al. EMBO JOURNAL
- Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells
- (2011) Anna I. Markowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
- (2010) R. K. Shrimali et al. CANCER RESEARCH
- A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice
- (2010) N. Demotte et al. CANCER RESEARCH
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
- (2009) Pierre Vereecken et al. MELANOMA RESEARCH
- Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse
- (2009) H.-Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started